Venrock Associates VII, L.P.'s Net Worth

$512 Million

Estimate Recalculated Feb 27, 2024 08:53PM EST

Who is Venrock Associates VII, L.P.?

Venrock Associates VII, L.P. has an estimated net worth of $512 Million. This is based on reported shares across multiple companies, which include Shockwave Medical, Inc., and Cyteir Therapeutics, Inc..

SEC CIK

Venrock Associates VII, L.P.'s CIK is 0001614766

Past Insider Trading and Trends

2019 was Venrock Associates VII, L.P.'s most active year for acquiring shares with 4 total transactions. Venrock Associates VII, L.P.'s most active month to acquire stocks was the month of February. 2021 was Venrock Associates VII, L.P.'s most active year for disposing of shares, totalling 2 transactions. Venrock Associates VII, L.P.'s most active month to dispose stocks was the month of May. 2021 saw Venrock Associates VII, L.P. paying a total of $0.00 for 3,259,025 shares, this is the most they've acquired in one year. In 2021 Venrock Associates VII, L.P. cashed out on 11,109,368 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Shockwave Medical, Inc. (SWAV) Snapshot price: $236.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.12M
2.12M
Mar 11
Form 3
0
0
No matching records found

Cyteir Therapeutics, Inc. (CYT) Snapshot price: $3.125

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.26M
3.26M
Jun 22
Form 3
0
0
No matching records found